Skip To The Main Content
Jessica A. Asrat
 

Jessica A. Asrat

Partner
 
425 Lexington Avenue
New York, NY 10017 
Jessica Asrat, a Partner in the Firm’s Capital Markets Practice, advises private equity sponsors, corporate issuers and investment banks in connection with a range of complex registered and unregistered transactions, including initial public offerings, high yield and investment grade debt offerings, spin-offs and other corporate finance transactions. She also has experience in acquisition financings and provides securities law advice in connection with M&A transactions. Jessica’s transactional work spans several industries, including the healthcare, consumer and retail, industrials and manufacturing and technology sectors. She was recently named as a  Law360 “Rising Star” in Capital Markets.

Read Full Biography...

Work Highlights
  • Avantor in its $4.37 billion IPO - the largest healthcare IPO in U.S. history and the second largest IPO in 2019
  • KKR in its $2.13 billion high yield debt and preferred equity financing for its acquisition of BMC Software
  • Dell Technologies in the spin-off of its 81% equity ownership interest in VMware
  • Avantor and New Mountain Capital in the high yield debt and preferred equity financing of Avantor’s acquisition of VWR
  • Broadcom in connection with $100 billion of committed debt financing for its proposed acquisition of Qualcomm
  • Special Committee of BellRing Brands in connection with Post Holdings’ spin-off of BellRing Brands, as well as BellRing Brands in a series of debt-for-equity follow-on transactions
  • Underwriters in Signify Health’s $649 million IPO
Education
  • Yale Law School, 2014 J.D.
  • Princeton University, 2009 A.B.
    summa cum laude; Isidore and Helen Sacks Memorial Prize; Ruth J. Simmons Thesis Prize
Admissions
  • New York 2016

Jessica Asrat, a Partner in the Firm’s Capital Markets Practice, advises private equity sponsors, corporate issuers and investment banks in connection with a range of complex registered and unregistered transactions, including initial public offerings, high yield and investment grade debt offerings, spin-offs and other corporate finance transactions. She also has experience in acquisition financings and provides securities law advice in connection with M&A transactions. Jessica’s transactional work spans several industries, including the healthcare, consumer and retail, industrials and manufacturing and technology sectors. She was recently named as a  Law360 “Rising Star” in Capital Markets.

Representative transactions on which Jessica has worked include advising:

  • Avantor in its $4.37 billion IPO - the largest healthcare IPO in U.S. history and the second largest IPO in 2019
  • KKR in its $2.13 billion high yield debt and preferred equity financing for its acquisition of BMC Software
  • Dell Technologies in the spin-off of its 81% equity ownership interest in VMware
  • Avantor and New Mountain Capital in the high yield debt and preferred equity financing of Avantor’s acquisition of VWR
  • Broadcom in connection with $100 billion of committed debt financing for its proposed acquisition of Qualcomm
  • Special Committee of BellRing Brands in connection with Post Holdings’ spin-off of BellRing Brands, as well as BellRing Brands in a series of debt-for-equity follow-on transactions
  • Underwriters in Signify Health’s $649 million IPO
  • Initial purchasers in high yield debt financing transactions, including offerings by THOR Industries, Dealer Tire and Charles River Laboratories

Jessica received her J.D. from Yale Law School in 2014 and her A.B., summa cum laude, from Princeton University in 2009. She is admitted to practice in New York.

News & Events

    Publications